Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A20 controls intestinal homeostasis through cell-specific activities.
Vereecke L, Vieira-Silva S, Billiet T, van Es JH, Mc Guire C, Slowicka K, Sze M, van den Born M, De Hertogh G, Clevers H, Raes J, Rutgeerts P, Vermeire S, Beyaert R, van Loo G. Vereecke L, et al. Among authors: billiet t. Nat Commun. 2014 Sep 30;5:5103. doi: 10.1038/ncomms6103. Nat Commun. 2014. PMID: 25267258 Free article.
Differences between adults and children: genetics and beyond.
Billiet T, Vermeire S. Billiet T, et al. Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):191-6. doi: 10.1586/17474124.2014.950228. Epub 2014 Aug 19. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25134842 Review.
Targeting TNF-α for the treatment of inflammatory bowel disease.
Billiet T, Rutgeerts P, Ferrante M, Van Assche G, Vermeire S. Billiet T, et al. Expert Opin Biol Ther. 2014 Jan;14(1):75-101. doi: 10.1517/14712598.2014.858695. Epub 2013 Nov 11. Expert Opin Biol Ther. 2014. PMID: 24206084 Review.
Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease.
de Bruyn M, Machiels K, Vandooren J, Lemmens B, Van Lommel L, Breynaert C, Van der Goten J, Staelens D, Billiet T, De Hertogh G, Ferrante M, Van Assche G, Vermeire S, Opdenakker G, Schuit F, Rutgeerts P, Arijs I. de Bruyn M, et al. Among authors: billiet t. Inflamm Bowel Dis. 2014 Feb;20(2):339-52. doi: 10.1097/01.MIB.0000438430.15553.90. Inflamm Bowel Dis. 2014. PMID: 24378596 Clinical Trial.
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis.
Papamichael K, Van Stappen T, Vande Casteele N, Gils A, Billiet T, Tops S, Claes K, Van Assche G, Rutgeerts P, Vermeire S, Ferrante M. Papamichael K, et al. Among authors: billiet t. Clin Gastroenterol Hepatol. 2016 Apr;14(4):543-9. doi: 10.1016/j.cgh.2015.11.014. Epub 2015 Dec 8. Clin Gastroenterol Hepatol. 2016. PMID: 26681486
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis.
Arias MT, Vande Casteele N, Vermeire S, de Buck van Overstraeten A, Billiet T, Baert F, Wolthuis A, Van Assche G, Noman M, Hoffman I, D'Hoore A, Gils A, Rutgeerts P, Ferrante M. Arias MT, et al. Among authors: billiet t. Clin Gastroenterol Hepatol. 2015 Mar;13(3):531-8. doi: 10.1016/j.cgh.2014.07.055. Epub 2014 Aug 10. Clin Gastroenterol Hepatol. 2015. PMID: 25117777
60 results